<DOC>
	<DOCNO>NCT00720382</DOCNO>
	<brief_summary>The purpose study determine one allergy treatment ( 0.15 % azelastine hydrochloride ) safe mometasone furoate ( nasonex ) alone .</brief_summary>
	<brief_title>A Study Evaluate Safety Tolerability Nasal Spray Treat Perennial Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<mesh_term>Azelastine</mesh_term>
	<criteria>Male female patient 12 year older compatible history great equal 1 year rhinitis due perennial allergy . Must willing able provide inform consent participate study procedure Must generally good health Positive skin test prevalent perennial allergen On nasal examination , presence nasal mucosal erosion , nasal ulceration nasal septal perforation Use investigational drug within 30 day first visit Any nasal surgery sinus surgery within previous year Presence hypersensitivity drug similar azelastine mometasone furoate either sorbital sucralose Women pregnant nursing Women use acceptable method birth control Nasal Diseases likely affect deposition intranasal medication , sinusitis , rhinitis medicamentosa clinically significant nasal polyposis nasal structural abnormality . Asthma lung disease COPD . Mild asthma symptom may consider consultation investigator . Patients Arrythmia Patients know history alcohol drug abuse Existence surgical medical condition , opinion investigator sponsor , might significantly alter evaluation study . Use medication could affect study result</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>